Kim Kamdar
SlowingNamed in filings at Domain PartnersOn the current fund
- Board seats filed
- 7
- Named on a board
- 1
all filings on record
Named in filings at Domain PartnersOn the current fund
all filings on record
last 24 months
from a verified or cited source
| Savanna Biotherapeutics | Biotech & pharma | June 2025 | None on file |
| Alume Biosciences | Biotech & pharma | August 2020 | None on file |
| Evofem Biosciences | Biotech & pharma | February 2019 | IPI Partners, Stack Infrastructure |
| Tragara Pharmaceuticals | Biotech & pharma | July 2015 | Lightstone Ventures |
| SERA PROGNOSTICS | Digital health | September 2013 | 270 Healthcare Growth |
| OBALON THERAPEUTICS | Medical devices | February 2012 | None on file |
| Aria Diagnostics | Healthcare services | November 2011 | None on file |
The company and date are what the SEC filing shows, not a statement of investment thesis. A partner can sit on a board for reasons that say nothing about what their firm funds today. The sector is not a filing value: it is Lev’s own classification of each company, shown only when we found a specific, checkable source for it; otherwise it reads “Not yet classified.” “Also on the board from” names another tracked firm with a partner on the same board, both with a clean identity match. It is not a claim either firm led or co-led the round, and “None on file” means no other tracked firm’s partner shares this specific board seat, not that no one else invested. Sorted newest first by default; click a column to change it. Something wrong? Tell us.
Classified sectors of companies where filings name Kim Kamdar on the board, based on 7 filed seats with a verified or cited source.